21.03.2022 07:00 | AVCT | Directorate Change | RNS |
16.03.2022 11:38 | AVCT | Avacta sells veterinary division to Vimian for up to GBP2.3 million | Alliance |
16.03.2022 07:00 | AVCT | Vimian acquires Avacta’s Animal Health Division | RNS |
14.02.2022 16:41 | AVCT | Second Price Monitoring Extn | RNS |
14.02.2022 16:36 | AVCT | Price Monitoring Extension | RNS |
07.02.2022 16:36 | AVCT | Price Monitoring Extension | RNS |
03.02.2022 17:26 | AVCT | Issue of Equity and Total Voting Rights | RNS |
03.02.2022 16:41 | AVCT | Second Price Monitoring Extn | RNS |
03.02.2022 16:35 | AVCT | Price Monitoring Extension | RNS |
03.02.2022 11:10 | AVCT | Avacta shares up 12% after chemotherapy drug advances to next stage | Alliance |
03.02.2022 07:00 | AVCT | Dose escalation in the phase I trial of AVA6000 | RNS |
31.01.2022 16:41 | AVCT | Second Price Monitoring Extn | RNS |
31.01.2022 16:36 | AVCT | Price Monitoring Extension | RNS |
18.01.2022 07:00 | AVCT | Second pre|CISION Pro-drug Candidate Selected | RNS |
12.01.2022 14:05 | AVCT | Second Price Monitoring Extn | RNS |
12.01.2022 14:00 | AVCT | Price Monitoring Extension | RNS |
10.01.2022 07:00 | AVCT | Update on AffiDX and detection of Omicron variant | RNS |
04.01.2022 11:06 | AVCT | Second Price Monitoring Extn | RNS |
04.01.2022 11:01 | AVCT | Price Monitoring Extension | RNS |
22.12.2021 16:26 | AVCT | Issue of Equity and Total Voting Rights | RNS |
22.12.2021 11:05 | AVCT | Second Price Monitoring Extn | RNS |
22.12.2021 11:00 | AVCT | Price Monitoring Extension | RNS |
22.12.2021 07:00 | AVCT | AffiDX Receives CE Mark for Consumer Self-Testing | RNS |
16.12.2021 07:00 | AVCT | Issue of Equity and Total Voting Rights | RNS |
15.12.2021 07:00 | AVCT | AffiDx® lateral flow test detects Omicron variant | RNS |
15.12.2021 07:00 | AVCT | Change of auditor | RNS |
29.11.2021 07:00 | AVCT | FDA Approval of IND Application for AVA6000 | RNS |
18.11.2021 16:41 | AVCT | Second Price Monitoring Extn | RNS |
18.11.2021 16:36 | AVCT | Price Monitoring Extension | RNS |
02.11.2021 07:00 | AVCT | Update on UK Availability of AffiDX Test | RNS |
14.10.2021 16:36 | AVCT | Price Monitoring Extension | RNS |
14.10.2021 12:36 | AVCT | Issue of Equity and Total Voting Rights | RNS |
30.09.2021 07:00 | AVCT | Interim Results for the Period Ended 30 June 2021 | RNS |
29.09.2021 07:00 | AVCT | Development Milestone in LG Chem Partnership | RNS |
22.09.2021 16:41 | AVCT | Second Price Monitoring Extn | RNS |
22.09.2021 16:35 | AVCT | Price Monitoring Extension | RNS |
09.09.2021 07:00 | AVCT | Notice of Results | RNS |
06.09.2021 07:00 | AVCT | New appointments to Scientific Advisory Board | Reach |
02.09.2021 07:00 | AVCT | Appointment of Chief Scientific Officer | Reach |
25.08.2021 16:40 | AVCT | Second Price Monitoring Extn | RNS |
25.08.2021 16:35 | AVCT | Price Monitoring Extension | RNS |
18.08.2021 07:00 | AVCT | Directorate Change | RNS |
11.08.2021 07:00 | AVCT | First Patient Dosed in AVA6000 Phase 1 Trial | RNS |
04.08.2021 07:00 | AVCT | Update on AffiDX Lateral Flow Test | RNS |
14.07.2021 07:00 | AVCT | Diagnostics achieves ISO 13485 Certification | RNS |
12.07.2021 16:41 | AVCT | Second Price Monitoring Extn | RNS |
12.07.2021 16:35 | AVCT | Price Monitoring Extension | RNS |
29.06.2021 07:00 | AVCT | AffiDX Lateral Flow Test Detects Delta Variant | RNS |
28.06.2021 12:13 | AVCT | Result of AGM | RNS |
21.06.2021 14:05 | AVCT | Second Price Monitoring Extn | RNS |
21.06.2021 14:00 | AVCT | Price Monitoring Extension | RNS |
21.06.2021 07:00 | AVCT | AffiDX Lateral Flow Test Distribution Agreement | RNS |
15.06.2021 08:00 | AVCT | Issue of Equity and Total Voting Rights | RNS |
11.06.2021 14:05 | AVCT | Second Price Monitoring Extn | RNS |
11.06.2021 14:00 | AVCT | Price Monitoring Extension | RNS |
11.06.2021 11:07 | AVCT | Registration of AffiDX Lateral Flow Test in EU | RNS |
09.06.2021 09:08 | AVCT | Holding(s) in Company | RNS |
07.06.2021 07:00 | AVCT | MHRA Confirms Registration of Lateral Flow Test | RNS |
01.06.2021 07:00 | AVCT | Update on Lateral Flow Test Regulatory Submissions | RNS |
28.05.2021 07:00 | AVCT | Response to speculation | RNS |
25.05.2021 10:00 | AVCT | Posting of Annual Report and Notice of AGM | RNS |
10.05.2021 10:36 | AVCT | AffiDX SARS-CoV-2 Antigen Lateral Flow Test Update | RNS |
06.05.2021 07:00 | AVCT | Change of Nominated Adviser | RNS |
30.04.2021 12:37 | AVCT | Issue of Equity | RNS |
28.04.2021 17:18 | AVCT | Issue of Equity | RNS |
28.04.2021 16:41 | AVCT | Second Price Monitoring Extn | RNS |
28.04.2021 16:36 | AVCT | Price Monitoring Extension | RNS |
22.04.2021 07:00 | AVCT | Final Results | RNS |
20.04.2021 11:05 | AVCT | Second Price Monitoring Extn | RNS |
20.04.2021 11:00 | AVCT | Price Monitoring Extension | RNS |
20.04.2021 07:00 | AVCT | Clinical validation of AffiDX Lateral Flow Test | RNS |
15.04.2021 16:36 | AVCT | Price Monitoring Extension | RNS |
13.04.2021 07:00 | AVCT | Notice of Results and Investor Presentation | RNS |
12.04.2021 13:30 | AVCT | Issue of Equity | RNS |
06.04.2021 07:00 | AVCT | Distribution Agreement with ABCAM plc | RNS |